Finally, histone deacetylase inhibitors (HDACis), which activate pro-inflammatory transcription factors such as STAT 1/3 and NF-κB, are being investigated for future therapeutic potential to arrest tumor growth and promote cancer cell apoptosis in both in vivo and in vitro models [389,390]. The gene discussed is NFKB1; the disease is cancer.